-
Call Us
-
E-mail Us
- Request A Quote
About Us
GenPep Pharmaceuticals
Precision in Pharmaceutical Innovation
The use of synthetic peptides approved by the health authorities for vaccines, cancer, and drug delivery systems is increasing with these developments. Due to limited expertise in this field, there is tremendous pressure to fulfill the huge market demand for the Peptides.
Our Goal at GenPep Pharmaceuticals is to utilize our expertise in Peptides and Oligonucleotides to develop and deliver a product inlined as per the regulatory requirement with cost-effective technologies.
About Our Foundation
Advancing Peptide & Oligonucleotide Innovation
Our Mission
To demonstrate and apply our scientific expertise in developing and manufacturing complex Peptides and Oligonucleotides with precision, quality, and regulatory compliance. We are committed to delivering high-performance drug molecules that support innovation in research and advanced pharmaceutical applications.
Our Vision
To establish ourselves as a leading Peptide API manufacturing company and CRAMS organization specializing in Peptides and Oligonucleotides. We aim to provide comprehensive solutions across peptide API development, formulations cosmetic applications and sequencing services, contributing to global healthcare advancements
Our Goal
To support our clients at every stage of product development from early research and discovery to large-scale commercial GMP-grade manufacturing. We strive to combine cost-effective technologies with regulatory excellence to ensure reliable, scalable, and high-quality outcomes.
Years Of Exps.
Permanent Staff
Test Completed
Wining Awards
Development & Manufacturing
The Future We Build
GenPep Pharmaceuticals Pvt. Ltd. is a science-driven pharmaceutical organization specializing in the development and manufacturing of Generic and Novel Peptide & Oligonucleotide drug molecules. With strong expertise in biotechnology and regulatory-compliant processes, we serve research institutions, pharmaceutical companies, and formulation partners across domestic and global markets.
